IBRD only vs Malta: Cause of death, by non-communicable diseases, female
IBRD only
68.6%
in 2021
Malta
84.5%
in 2021
IBRD only rank
18th
Malta rank
19th
Cause of death, by non-communicable diseases, female over time
- IBRD only
- Malta
How they compare
Malta currently reports 84.5% against 68.6% in IBRD only, a difference of 15.9%.
That makes Malta's figure about 1.2 times IBRD only's.
Across all 6 years both countries report, Malta has been ahead every year.
IBRD only ranks 18th and Malta ranks 19th of 47 groups.
Malta has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IBRD only | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 66.5% | 89.2% | 22.7% | Malta |
| 2010s | 78.5% | 90.4% | 11.9% | Malta |
| 2020s | 72.0% | 85.0% | 13.1% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, IBRD only or Malta?
- Malta, at 84.5% against 68.6% in IBRD only as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between IBRD only and Malta?
- 15.9%, with Malta ahead.
- How many years of comparable data are there for IBRD only and Malta?
- 6 years are reported by both, from 2000 to 2021.
- How do IBRD only and Malta rank globally for cause of death, by non-communicable diseases, female?
- IBRD only ranks 18th and Malta ranks 19th of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.